Journal
PHARMACEUTICAL STATISTICS
Volume 8, Issue 2, Pages 125-135Publisher
JOHN WILEY & SONS INC
DOI: 10.1002/pst.341
Keywords
adaptive design; phase II trial; sample size review; sequential analysis; two-stage design
Categories
Funding
- Medical Research Council [G0800792] Funding Source: Medline
- Medical Research Council [G0800792] Funding Source: researchfish
- MRC [G0800792] Funding Source: UKRI
Ask authors/readers for more resources
Two-stage designs offer substantial advantages for early phase II studies. The interim analysis following the first stage allows the study to he stopped for futility, or more positively, it might lead to early progression to the trials needed for late phase H and phase III. If the study is to continue to its second stage, then there is an opportunity for a revision of the total sample size. Two-stage designs have been implemented widely in oncology studies in which there is a single treatment arm and patient responses are binary. In this paper the case of two-arm comparative studies in which responses are quantitative is considered. This setting is common in therapeutic areas other than oncology. It will be assumed that observations are normally distributed, but that there is some doubt concerning their standard deviation, motivating the need for sample size review. The work reported has been motivated by a study in diabetic neuropathic pain, and the development of the design for that trial is described in detail. Copyright (C) 2008 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available